04/01/2024 3:37 PM | Alnylam Pharmaceuticals (Filer)
| Form ARS | |
04/01/2024 3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form DEF 14A | |
03/04/2024 3:33 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 3:16 PM | Alnylam Pharmaceuticals (Issuer) Franchini Indrani Lall (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:17 PM | Alnylam Pharmaceuticals (Issuer) Garg Pushkal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:18 PM | Alnylam Pharmaceuticals (Issuer) Greenstreet Yvonne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:18 PM | Alnylam Pharmaceuticals (Issuer) Poulton Jeffrey V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/29/2024 3:18 PM | Alnylam Pharmaceuticals (Issuer) Tanguler Tolga (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:00 PM | Alnylam Pharmaceuticals (Subject) SHARP PHILLIP A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 7:35 AM | Alnylam Pharmaceuticals (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:40 AM | Alnylam Pharmaceuticals (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/05/2024 3:05 PM | Alnylam Pharmaceuticals (Issuer) Franchini Indrani Lall (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 11:18 AM | Alnylam Pharmaceuticals (Subject) BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/19/2024 3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 6:00 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023 6:30 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 6:30 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 4:00 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 5:04 PM | Alnylam Pharmaceuticals (Issuer) Vaishnaw Akshay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:04 PM | Alnylam Pharmaceuticals (Issuer) Greenstreet Yvonne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:05 PM | Alnylam Pharmaceuticals (Issuer) Poulton Jeffrey V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:05 PM | Alnylam Pharmaceuticals (Issuer) Garg Pushkal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 7:18 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/30/2023 8:03 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 3:30 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |